{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T08:07:17Z","timestamp":1783670837479,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jaad.2015.07.049","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T00:37:26Z","timestamp":1445215046000},"page":"S42-S46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"S1","title":["Scientific evidence for the use of current traditional systemic therapies in patients with hidradenitis suppurativa"],"prefix":"10.1016","volume":"73","author":[{"given":"Raed","family":"Alhusayen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil H.","family":"Shear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2015.07.049_bib1","first-page":"827","article-title":"Treatment experience in a local population with hidradenitis suppurativa","volume":"13","author":"Kohorst","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/11631880-000000000-00000","article-title":"Pharmacologic interventions for hidradenitis suppurativa","volume":"13","author":"Alhusayen","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib3","doi-asserted-by":"crossref","unstructured":"Ingram JR, McPhee M. Management of hidradenitis suppurativa: a UK survey of current practice. Br J Dermatol. doi: http:\/\/dx.doi.org\/10.1111\/bjd.13866. Published online April 27, 2015.","DOI":"10.1111\/bjd.13866"},{"key":"10.1016\/j.jaad.2015.07.049_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-4632.2004.02536.x","article-title":"\u201cHidradenitis suppurativa\u201d is acne inversa! An appeal to (finally) abandon a misnomer","volume":"44","author":"Sellheyer","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2133.2011.10643.x","article-title":"Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions","volume":"166","author":"van der Zee","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF01743360","article-title":"Immunomodulating effects of antibiotics: literature review","volume":"24","author":"Van Vlem","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.jaad.2015.07.049_bib8","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2340\/00015555-1841","article-title":"Bacteriology of hidradenitis suppurativa\u2013which antibiotics are the treatment of choice?","volume":"94","author":"Matusiak","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2015.07.049_bib9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1365-2133.2006.07155.x","article-title":"Clindamycin and rifampicin combination therapy for hidradenitis suppurativa","volume":"154","author":"Mendon\u00e7a","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","article-title":"Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients","volume":"219","author":"Gener","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2015.07.049_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000228337","article-title":"The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa","volume":"219","author":"van der Zee","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2015.07.049_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jdv.12127","article-title":"Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa\/acne inversa: a prospective study on 23 patients","volume":"28","author":"Bettoli","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2015.07.049_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1017\/ice.2014.39","article-title":"Comorbidities, exposure to medications, and the risk of community-acquired Clostridium difficile infection: a systematic review and meta-analysis","volume":"36","author":"Luis","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jaad.2015.07.049_bib14","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/jac\/dkt129","article-title":"Community-associated Clostridium difficile infection and antibiotics: a meta-analysis","volume":"68","author":"Abhishek","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaad.2015.07.049_bib15","first-page":"340","article-title":"Surveillance for community-associated Clostridium difficile\u2014Connecticut, 2006","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaad.2015.07.049_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/cid\/cir301","article-title":"Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection","volume":"53","author":"Vanes","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2015.07.049_bib17","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2165\/00003088-200342090-00003","article-title":"Pharmacokinetic interactions with rifampicin","volume":"42","author":"Mikko","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jaad.2015.07.049_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1684\/ejd.2013.2213","article-title":"Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination","volume":"24","author":"Join-Lambert","year":"2014","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa","volume":"39","author":"Jemec","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib20","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/archderm.1997.03890460044005","article-title":"Comparative safety of tetracycline, minocycline, and doxycycline","volume":"133","author":"Shapiro","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1067\/mjd.2001.114733","article-title":"Dapsone and sulfones in dermatology: overview and update","volume":"45","author":"Zhu","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001050170015","article-title":"Acne inversa Eine Dapson-sensitive Dermatose","volume":"52","author":"Hofer","year":"2001","journal-title":"Der Hautarzt"},{"key":"10.1016\/j.jaad.2015.07.049_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/09546630600830588","article-title":"Hidradenitis suppurativa treated with dapsone: a case series of five patients","volume":"17","author":"Kaur","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2015.07.049_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000329023","article-title":"Dapsone therapy for hidradenitis suppurativa: a series of 24 patients","volume":"222","author":"Yazdanyar","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2015.07.049_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000321716","article-title":"Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa","volume":"222","author":"Join-Lambert","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2015.07.049_bib26","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/375078","article-title":"Fluoroquinolone-associated tendinopathy: a critical review of the literature","volume":"36","author":"Khaliq","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2015.07.049_bib27","first-page":"1","article-title":"Hidradenitis suppurativa: a practical review of possible medical treatments based on over 350 hidradenitis patients","volume":"19","author":"Scheinfeld","year":"2013","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2015.07.049_bib28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00054725-200111000-00008","article-title":"Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab","volume":"7","author":"Mart\u00ednez","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaad.2015.07.049_bib29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0190-9622(88)80251-2","article-title":"Successful treatment of hidradenitis suppurativa with acitretin","volume":"19","author":"Hogan","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib30","first-page":"287","article-title":"Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report","volume":"69","author":"Scheman","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2015.07.049_bib31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2010.10071.x","article-title":"Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer?","volume":"164","author":"Boer","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bjd.12884","article-title":"Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients","volume":"171","author":"Matusiak","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib33","first-page":"155","article-title":"Alitretinoin: a useful agent in the treatment of hidradenitis suppurativa, especially in women of child-bearing age","volume":"150","author":"Verdolini","year":"2015","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaad.2015.07.049_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0190-9622(99)70530-X","article-title":"Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa","volume":"40","author":"Boer","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000182261","article-title":"Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment","volume":"218","author":"Soria","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2015.07.049_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2133.1986.tb05740.x","article-title":"A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa","volume":"115","author":"Mortimer","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMct0707092","article-title":"Metformin for the treatment of the polycystic ovary syndrome","volume":"358","author":"Nestler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2015.07.049_bib38","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","article-title":"Metformin for the treatment of hidradenitis suppurativa: a little help along the way","volume":"27","author":"Verdolini","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2015.07.049_bib39","first-page":"732","article-title":"Finasteride for the treatment of hidradenitis suppurativa in children and adolescents","volume":"149","author":"Randhawa","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2310\/7750.2007.00019","article-title":"Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy","volume":"11","author":"Kraft","year":"2007","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2015.07.049_bib41","first-page":"289P","article-title":"Cyclosporine-responsive hidradenitis suppurativa","volume":"88","author":"Buckley","year":"1995","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jaad.2015.07.049_bib42","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2230.2005.01983.x","article-title":"Treatment of recalcitrant hidradenitis suppurativa with oral cyclosporine","volume":"31","author":"Rose","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib43","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1016\/j.jaad.2012.06.011","article-title":"Recalcitrant severe hidradenitis suppurativa successfully treated with cyclosporine A","volume":"67","author":"Bianchi","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib44","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/j.jaad.2014.06.031","article-title":"Hidradenitis suppurativa after renal transplantation: complete remission after switching from oral cyclosporine to oral tacrolimus","volume":"71","author":"Ducroux","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib45","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/01.tp.0000235170.21344.07","article-title":"Inactivity of hidradenitis suppurativa after renal transplantation","volume":"82","author":"Arnadottir","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2015.07.049_bib46","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2015.07.049_bib47","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2230.2002.11125.x","article-title":"Methotrexate is of limited value in the treatment of hidradenitis suppurativa","volume":"27","author":"Jemec","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib48","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1600-0625.2012.01552.x","article-title":"Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments","volume":"21","author":"van der Zee","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000100883","article-title":"Hidradenitis suppurativa and zinc: a new therapeutic approach","volume":"214","author":"Brocard","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2015.07.049_bib50","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/bjd.13346","article-title":"Fumarates, a new treatment option for therapy-resistant hidradenitis suppurativa: a prospective open-label pilot study","volume":"172","author":"Deckers","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2015.07.049_bib51","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.4049\/jimmunol.168.9.4781","article-title":"Dimethylfumarate inhibits TNF-induced nuclear entry of NF-\u03baB\/p65 in human endothelial cells","volume":"168","author":"Loewe","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2015.07.049_bib52","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1084\/jem.20100977","article-title":"Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells","volume":"208","author":"Ghoreschi","year":"2011","journal-title":"J Exp Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215019970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215019970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:36:37Z","timestamp":1759271797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962215019970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0190962215019970"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2015.07.049","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scientific evidence for the use of current traditional systemic therapies in patients with hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2015.07.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}